Patents by Inventor Lisa Iddon

Lisa Iddon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10821194
    Abstract: The present invention pertains generally to the field of imaging compounds, and more specifically to certain 2,2-dialkyl radionuclide-labelled carboxylic acids suitable for PET, SPECT and/or DNP imaging. Also described are used of such compounds in the imaging of inter alia, cancer tumours, metastasis, Alzheimer's disease and multiple sclerosis.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: November 3, 2020
    Assignee: Cancer Research Technologies Limited
    Inventors: Eric O. Aboagye, Lisa Iddon, Federica Pisaneschi, Timothy H. Witney
  • Publication number: 20190184039
    Abstract: The present invention pertains generally to the field of imaging compounds, and more specifically to certain 2,2-dialkyl radionuclide-labelled carboxylic acids suitable for PET, SPECT and/or DNP imaging. Also described are used of such compounds in the imaging of inter alia, cancer tumours, metastasis, Alzheimer's disease and multiple sclerosis.
    Type: Application
    Filed: February 21, 2019
    Publication date: June 20, 2019
    Inventors: Eric O. Aboagye, Lisa Iddon, Federica Pisaneschi, Timothy H. Witney
  • Patent number: 10213516
    Abstract: The present invention pertains generally to the field of imaging compounds, and more specifically to certain 2,2-dialkyl radionuclide-labelled carboxylic acids suitable for PEWT, SPECT and/or DNP imaging. Also described are uses of such compounds in the imaging of, inter alia, cancer tumors, metastasis, Alzheimer's disease and multiple sclerosis.
    Type: Grant
    Filed: May 8, 2014
    Date of Patent: February 26, 2019
    Inventors: Eric O. Aboagye, Lisa Iddon, Federica Pisaneschi, Timothy H. Witney
  • Patent number: 10201625
    Abstract: Novel radiotracer(s) for Positron Emission Tomography (PET) imaging are described. Novel radiotracer(s) for Positron Emission Tomography (PET) imaging of neuorendocrine tumors are described. Specifically the present invention describes novel [18F]Fluoroethyltriazol-[Tyr3]Octreotate analogs; in particular those that target somatostatin receptors found on the cell surface of gastroenteropancreatic neuorendocrine tumors. The present invention also describes intermediate(s), precursor(s), pharmaceutical composition(s), methods of making, and methods of use of the novel radiotracer(s).
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: February 12, 2019
    Assignees: IMPERIAL COLLEGE, GE HEALTHCARE LIMITED
    Inventors: Sajinker Kaur Luthra, Julius Leyton, Eric Ofori Aboagye, Lisa Iddon, Bard Indrevoll, Matthias Eberhard Glaser, Alan Cuthbertson
  • Publication number: 20160095946
    Abstract: The present invention pertains generally to the field of imaging compounds, and more specifically to certain 2,2-dialkyl radionuclide-labelled carboxylic acids suitable for PEWT, SPECT and/or DNP imaging. Also described are uses of such compounds in the imaging of, inter alia, cancer tumors, metastasis, Alzheimer's disease and multiple sclerosis.
    Type: Application
    Filed: May 8, 2014
    Publication date: April 7, 2016
    Inventors: Eric O. Aboagye, Lisa Iddon, Federica Pisaneschi, Timothy H. Witney
  • Publication number: 20140097078
    Abstract: A click chemistry process to be performed with an automated synthesis device using a synthesis cassette includes the steps of performing a chemical reaction in a first vessel at a first elevated temperature, heating the first vessel to a second elevated temperature to cause distillation, delivering a distilled reaction product from the first vessel to a second vessel, performing a click chemistry reaction with the distilled reaction product in the second vessel, purifying the click chemistry product, and formulating a final product from the purified click chemistry product. A cassette and a kit of parts for performing the process are also provided.
    Type: Application
    Filed: June 7, 2012
    Publication date: April 10, 2014
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Lisa Iddon, Rajiv Bhalla, ANTHONY Wilson
  • Publication number: 20130343990
    Abstract: Novel radiotracer(s) for Positron Emission Tomography (PET) imaging are described. Novel radiotracer(s) for Positron Emission Tomography (PET) imaging of neuorendocrine tumors are described. Specifically the present invention describes novel [18F]Fluoroethyltriazol-[Tyr3]Octreotate analogs; in particular those that target somatostatin receptors found on the cell surface of gastroenteropancreatic neuorendocrine tumors. The present invention also describes intermediate(s), precursor(s), pharmaceutical composition(s), methods of making, and methods of use of the novel radiotracer(s).
    Type: Application
    Filed: March 1, 2012
    Publication date: December 26, 2013
    Applicants: IMPERIAL COLLEGE, GE HEALTHCARE LIMITED
    Inventors: Sajinker Kaur Luthra, Julius Leyton, Eric Ofori Aboagye, Lisa Iddon, Bard Indrevoll, Matthias Eberhard Glaser, Alan Cuthbertson